What is NDC 71863-135?

71863-135 is the product NDC for Impavido (miltefosine), Miltefosine 50 mg/1 capsule, listed with the FDA by Eton Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Eton Pharmaceuticals, Inc., NDC labeler code 71863. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Impavido?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Impavido NDC 71863-135 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71863-135Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71863-0135Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71863-135-28	71863013528	2 BLISTER PACK in 1 CARTON (71863-135-28) / 14 CAPSULE in 1 BLISTER PACKMarketed from Sep 26, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Impavido
Generic name (nonproprietary): miltefosine
Active ingredients: Miltefosine — 50 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Eton Pharmaceuticals, Inc.NDC labeler code 71863
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 204684
Marketing start: Sep 26, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 71863-135_57c515c8-f4b0-b876-e063-6394a90af0ccSPL ID 57c515c8-f4b0-b876-e063-6394a90af0cc
Pharmacologic class: Antileishmanial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471863013528 followed by a unit qualifier and the quantity

Package 71863-0135-28. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 71863-135

What is NDC 71863-135?: 71863-135 is the product NDC for Impavido (miltefosine), Miltefosine 50 mg/1 capsule, listed with the FDA by Eton Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Impavido (Miltefosine).
What is the active ingredient?: Miltefosine.
Who is the labeler?: Eton Pharmaceuticals, Inc., NDC labeler code 71863. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Impavido?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Impavido (Miltefosine) NDC 71863-135